Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	BYM338 70 mg	0	19
Total, all-cause mortality	BYM338 210 mg	0	18
Total, all-cause mortality	BYM338 700 mg	2	113
Total, all-cause mortality	Placebo	0	67
Total, other adverse events	BYM338 70 mg	12	19
Total, other adverse events	BYM338 210 mg	13	18
Total, other adverse events	BYM338 700 mg	94	113
Total, other adverse events	Placebo	41	67
Total, serious adverse events	BYM338 70 mg	0	19
Total, serious adverse events	BYM338 210 mg	3	18
Total, serious adverse events	BYM338 700 mg	14	113
Total, serious adverse events	Placebo	5	67

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02333331/event-totals